Current Concepts in the Treatment of Renovascular Hypertension.

Abstract

Renovascular disease (RVD) remains a major cause of secondary and treatment-resistant hypertension. Most cases are related either to fibromuscular or atherosclerotic lesions, but a variety of other causes including arterial dissection, stent occlusion, and embolic disease can produce the same syndrome. Recent studies emphasize the kidney's tolerance to moderate flow reduction during antihypertensive drug therapy and the relative safety of medical therapy to control blood pressure. Several prospective trials in moderate RVD fail to identify major benefits from endovascular revascularization for moderate atherosclerotic disease. However, high-risk and progressive renovascular syndromes are recognized to be relatively refractory to medical therapy only and respond better to combining renal revascularization with ongoing medical therapy. Clinicians caring for complex hypertension should be familiar with pathogenic pathways, imaging techniques, and a rational approach to managing renovascular hypertension in the current era.

• Authors: Sandra M Herrmann, Stephen C Textor
• Journal: American journal of hypertension (Am J Hypertens) Vol. 31 Issue 2 Pg. 139-149 (01 12 2018) ISSN: 1941-7225 [Electronic] United States
• PMID: 28985335 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
• Copyright: © American Journal of Hypertension, Ltd 2017. All rights reserved. For Permissions, please email: [email protected].

Chemical References

• Antihypertensive Agents

Topics

• Animals
• Antihypertensive Agents (adverse effects, therapeutic use)
• Blood Pressure (drug effects)
• Endovascular Procedures (adverse effects, instrumentation)
• Humans
• Hypertension, Renovascular (diagnosis, epidemiology, physiopathology, therapy)
• Renal Artery Obstruction (diagnosis, epidemiology, physiopathology, surgery)
• Risk Factors
• Stents
• Treatment Outcome